Salvage treatments after focal therapy for prostate cancer – a comprehensive review-Reference-Cited by-同舟云学术

Salvage treatments after focal therapy for prostate cancer – a comprehensive review

Published:2024-08-01 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Storino Ramacciotti Lorenzo^ORCID,Abreu Andre Luis^ORCID,Crouzet Sébastien,Macek Petr^ORCID,Miles Brian J.,Horuz Rahim,Nunes-Carneiro Diogo,Stricker Phillip^ORCID,Scionti Stephen,Laguna M. Pilar

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41391-024-00875-3.pdf

Reference39 articles.

1. Abreu AL, Peretsman S, Iwata A, Shakir A, Iwata T, Brooks J, et al. High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States Series. J Urol. 2020;204:741–7.

2. Abreu AL, Kaneko M, Cacciamani GE, Lebastchi AH. Focal therapy for prostate cancer: getting ready for prime time. Eur Urol. 2022;81:34–6.

3. Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, Fütterer JJ, Rovers MM. An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years? Eur Urol. 2022;81:5–33.

4. Ghoreifi A, Kaneko M, Peretsman S, Iwata A, Brooks J, Shakir A, et al. Patient-reported satisfaction and regret following focal therapy for prostate cancer: a prospective multicenter evaluation. Eur Urol Open Sci. 2023;50:10–6.

5. Reddy D, Peters M, Shah TT, van Son M, Tanaka MB, Huber PM, et al. Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol. 2022;81:407–13.